You are here

Article Text

Article menu
Download PDFPDF
Editorial
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues

https://doi.org/10.1136/bjo.2006.101337

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: In the past 2 years, clinical research support has been received from Genentech, Eyetech/OSI Pharmaceuticals and Alcon Laboratories. Dr Rosenfeld has participated in scientific advisory boards on behalf of Genentech, Novartis Ophthalmics, Allergan, BioAxone, PDL Biopharmaceuticals, Tanox, Jerini and Genaera. He also participates in the Genentech speakers’ bureau.

    Linked Articles